A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis
Clinical trial NCT03000673 · COMPLETED
Trial details
- NCT number
- NCT03000673
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-23
- Primary completion
- 2017-10-23
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.